PMID- 30288555 OWN - NLM STAT- MEDLINE DCOM- 20190626 LR - 20200225 IS - 1432-2323 (Electronic) IS - 0364-2313 (Linking) VI - 43 IP - 2 DP - 2019 Feb TI - Results of Duodenopancreatic Reoperations in Multiple Endocrine Neoplasia Type 1. PG - 552-558 LID - 10.1007/s00268-018-4809-1 [doi] AB - BACKGROUND: To evaluate the outcome of duodenopancreatic reoperations in patients with multiple endocrine neoplasia type 1 (MEN1). METHODS: MEN1 patients who underwent reoperations for duodenopancreatic neuroendocrine neoplasms (dpNENs) were retrieved from a prospective database and retrospectively analyzed. RESULTS: Twelve of 101 MEN1 patients underwent up to three reoperations, resulting in a total of 18 reoperations for dpNEN recurrence. Patients initially underwent either formal pancreatic resections (n = 7), enucleations (n = 3), or duodenotomy with lymphadenectomy for either NF-pNEN (seven patients), Zollinger-Ellison syndrome (ZES, three patients), organic hyperinsulinism (one patient) or VIPoma (one patient). Six patients had malignant dpNENs with lymph node (n = 5) and/or liver metastases (n = 2). The indication of reoperations was NF-pNEN (five patients), ZES (five patients), organic hyperinsulinism (one patient), and recurrent VIPoma (one patient). Median time to first reoperation was 67.5 (range 6-251) months. Five patients required a second duodenopancreatic reoperation for 60-384 months after initial surgery, and one patient underwent a third reoperation after 249 months. The rate of complications (Clavien-Dindo >/=3) was 28%. Four patients required completion pancreatectomy. Six patients developed pancreoprivic diabetes. After a median follow-up of 18 (6-34) years after initial surgery, ten of 12 patients are alive, one died of metastatic pancreatic VIPoma, and one died of metastatic thymic NEN. CONCLUSION: Reoperations are frequently necessary for dpNEN in MEN1 patients, but are not associated with an increased perioperative morbidity in specialized centers. Organ-sparing resections should be preferred as initial duodenopancreatic procedures to maintain pancreatic function and avoid completion pancreatectomy. FAU - Albers, Max B AU - Albers MB AD - Department of Visceral-, Thoracic- and Vascular Surgery, Philipps University of Marburg, Baldingerstr, 35043, Marburg, Germany. albersm@med.uni-marburg.de. FAU - Manoharan, Jerena AU - Manoharan J AD - Department of Visceral-, Thoracic- and Vascular Surgery, Philipps University of Marburg, Baldingerstr, 35043, Marburg, Germany. FAU - Bollmann, Carmen AU - Bollmann C AD - Department of Visceral-, Thoracic- and Vascular Surgery, Philipps University of Marburg, Baldingerstr, 35043, Marburg, Germany. FAU - Chlosta, Maximilian P AU - Chlosta MP AD - Department of Visceral-, Thoracic- and Vascular Surgery, Philipps University of Marburg, Baldingerstr, 35043, Marburg, Germany. FAU - Holzer, Katharina AU - Holzer K AD - Department of Visceral-, Thoracic- and Vascular Surgery, Philipps University of Marburg, Baldingerstr, 35043, Marburg, Germany. FAU - Bartsch, Detlef K AU - Bartsch DK AD - Department of Visceral-, Thoracic- and Vascular Surgery, Philipps University of Marburg, Baldingerstr, 35043, Marburg, Germany. LA - eng PT - Journal Article PL - United States TA - World J Surg JT - World journal of surgery JID - 7704052 SB - IM MH - Adult MH - Duodenal Neoplasms/*surgery MH - Duodenum/surgery MH - Female MH - Humans MH - Male MH - Middle Aged MH - Multiple Endocrine Neoplasia Type 1/*surgery MH - Pancreatectomy MH - Pancreatic Neoplasms/*surgery MH - Prospective Studies MH - *Reoperation MH - Retrospective Studies MH - Time Factors EDAT- 2018/10/06 06:00 MHDA- 2019/06/27 06:00 CRDT- 2018/10/06 06:00 PHST- 2018/10/06 06:00 [pubmed] PHST- 2019/06/27 06:00 [medline] PHST- 2018/10/06 06:00 [entrez] AID - 10.1007/s00268-018-4809-1 [pii] AID - 10.1007/s00268-018-4809-1 [doi] PST - ppublish SO - World J Surg. 2019 Feb;43(2):552-558. doi: 10.1007/s00268-018-4809-1.